Portal Vein Thrombosis
58
8
9
21
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.4%
2 terminated out of 58 trials
91.3%
+4.8% vs benchmark
24%
14 trials in Phase 3/4
10%
2 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (58)
Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis
Freiburg TIPS Registry
Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and Predictors
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
Indicators Affecting PVT Recanalization
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT
Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes
A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient
Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.
Chances in Portal System Flow After Two Bariatric Procedures
Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis
Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome